Mostra el registre parcial de l'element
Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling the energy balance
dc.contributor.author | Garcia-Chica, Jesús | |
dc.contributor.author | Paraiso, West Kristian | |
dc.contributor.author | Zagmutt, Sebastián | |
dc.contributor.author | Fosch, Anna | |
dc.contributor.author | Reguera, Ana Cristina | |
dc.contributor.author | Alzina, Sara | |
dc.contributor.author | Sánchez-García, Laura | |
dc.contributor.author | Fukushima, Shigeto | |
dc.contributor.author | Toh, Kazuko | |
dc.contributor.author | Casals, Núria | |
dc.contributor.author | Serra, Dolors | |
dc.contributor.author | Herrero, Laura | |
dc.contributor.author | Garcia Gomez, Jordi | |
dc.contributor.author | Kataoka, Kazunori | |
dc.contributor.author | Ariza, Xavier | |
dc.contributor.author | Quader, Sabina | |
dc.contributor.author | Rodriguez-Rodriguez, Rosalia | |
dc.date.accessioned | 2023-03-22T14:11:22Z | |
dc.date.available | 2023-03-22T14:11:22Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Garcia-Chica, Jesús; Paraiso, West Kristian; Zagmutt, Sebastián [et al.]. Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling the energy balance. Biomaterials Science, 2023, [p. 1-12]. Disponible en: <https://pubs.rsc.org/en/content/articlelanding/2023/BM/D2BM01751B>. Fecha de acceso: 22 mar. 2023. DOI: 10.1039/D2BM01751B | ca |
dc.identifier.issn | 2047-4849 | ca |
dc.identifier.uri | http://hdl.handle.net/20.500.12328/3633 | |
dc.description.abstract | Targeting brain lipid metabolism is a promising strategy to regulate the energy balance and fight metabolic diseases such as obesity. The development of stable platforms for selective delivery of drugs, particularly to the hypothalamus, is a challenge but a possible solution for these metabolic diseases. Attenuating fatty acid oxidation in the hypothalamus via CPT1A inhibition leads to satiety, but this target is difficult to reach in vivo with the current drugs. We propose using an advanced crosslinked polymeric micelle-type nanomedicine that can stably load the CPT1A inhibitor C75-CoA for in vivo control of the energy balance. Central administration of the nanomedicine induced a rapid attenuation of food intake and body weight in mice via regulation of appetite-related neuropeptides and neuronal activation of specific hypothalamic regions driving changes in the liver and adipose tissue. This nanomedicine targeting brain lipid metabolism was successful in the modulation of food intake and peripheral metabolism in mice. | en |
dc.format.extent | 12 | ca |
dc.language.iso | eng | ca |
dc.publisher | Royal Society of Chemistry | ca |
dc.relation.ispartof | Biomaterials Science | ca |
dc.relation.uri | https://pubs.rsc.org/en/content/articlelanding/2023/BM/D2BM01751B | ca |
dc.rights | This article is Open Access. | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/3.0/ | |
dc.subject.other | Metabolisme | ca |
dc.subject.other | Fàrmacs | ca |
dc.subject.other | Metabolismo | es |
dc.subject.other | Fármacos | es |
dc.subject.other | Metabolism | en |
dc.subject.other | Drugs | en |
dc.title | Nanomedicine targeting brain lipid metabolism as a feasible approach for controlling the energy balance | en |
dc.type | info:eu-repo/semantics/article | ca |
dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
dc.embargo.terms | cap | ca |
dc.subject.udc | 615 | ca |
dc.identifier.doi | https://dx.doi.org/10.1039/D2BM01751B | ca |
Fitxers en aquest element
Aquest element apareix en la col·lecció o col·leccions següent(s)
-
Ciències de la Salut [738]